dronabinol has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubinett, SM; Gardner, B; Roth, MD; Sharma, S; Stolina, M; Tashkin, DP; Zhu, LX | 1 |
1 other study(ies) available for dronabinol and Carcinoma, Lewis Lung
Article | Year |
---|---|
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Antigen-Presenting Cells; Carcinoma, Lewis Lung; Cell Division; Cytokines; Dronabinol; Growth Inhibitors; Immunity, Innate; Immunosuppressive Agents; Injections, Intraperitoneal; Interleukin-10; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Lymphocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Neoplasm Transplantation; Receptors, Cannabinoid; Receptors, Drug; Severe Combined Immunodeficiency; T-Lymphocytes; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |